Jewett Michael A. S. - Net Worth and Insider Trading

Jewett Michael A. S. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jewett Michael A. S. owns 2 companies in total, including Sesen Bio Inc (SESN) , and CARISMA Therapeutics Inc (CARM) .

Click here to see the complete history of Jewett Michael A. S.’s form 4 insider trades.

Insider Ownership Summary of Jewett Michael A. S.

Ticker Comapny Transaction Date Type of Owner
SESN Sesen Bio Inc 2021-07-20 director
CARM CARISMA Therapeutics Inc 2021-07-20 director

Jewett Michael A. S. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jewett Michael A. S. Ownership Network

Ownership Network List of Jewett Michael A. S.

No Data

Ownership Network Relation of Jewett Michael A. S.

Insider Network Chart

Jewett Michael A. S. Owned Company Details

What does Sesen Bio Inc do?

Who are the key executives at Sesen Bio Inc?

Jewett Michael A. S. is the director of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .

Sesen Bio Inc (SESN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sesen Bio Inc Insider Transactions

No Available Data

Jewett Michael A. S. Mailing Address

Above is the net worth, insider trading, and ownership report for Jewett Michael A. S.. You might contact Jewett Michael A. S. via mailing address: C/o Sesen Bio, Inc., 245 First Street, Suite 1800, Cambridge Ma 02142.

Discussions on Jewett Michael A. S.

No discussions yet.